Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

CRISPR/Cas9-Mediated PD-1 Engineered T Cells: New Strategy to Block Tumor Immune Escape

At present, overexpression of immune-related genes is one of the key mechanisms of tumor immune evasion. As a tumor cell-mediated immune escape core checkpoint molecule, the PD-L1 (programmed death ligand 1) will recruit SHP-1/SHP-2 (Src homology phosphotyrosyl phosphatase 1/ Src homology phosphotyrosyl phosphatase 2)...

Weiyan Xu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.